Počet záznamov: 1
18F-FDG uptake on PET could be a predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms?
SYS 0079305 LBL 00000naa^^22^^^^^^^^450 005 20150512070331.6 100 $a 20120808a2012 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a 18F-FDG uptake on PET could be a predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms? $f K. Kaira ... [et al.] 215 $c ilustr. (aj fareb.), fotogr., graf, obr., tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0078216 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 59, no. 3 (2012), s. 257-263 $1 210 $a Bratislava $c AEPress $d 2012 $1 215 $a s. 237-354 541 1-
$a Môže byť 18F-FDG PET vychytávanie prediktívnym markerom expresie excízneho reparačného proteínu komplementačnej skupiny 1 (ERCC1) u pacientov s nádormi hrudníka? $z slo 606 1-
$3 sllk_un_auth*d013899 $a nádory hrudníka $x patológia $x diagnostika rádioizotopová $2 mesh 606 2-
$3 sllk_un_auth*d008175 $a nádory pľúc $2 mesh 606 1-
$3 sllk_un_auth*d049268 $a tomografia pozitrónová emisná $2 mesh 606 2-
$3 sllk_un_auth*d019788 $a 18F fluórdeoxyglukóza $x použitie diagnostické $2 mesh 606 2-
$3 sllk_un_auth*d045643 $a enzýmy DNA reparačné $2 mesh 606 2-
$3 sllk_un_auth*d007150 $a imunohistochémia $2 mesh 606 2-
$3 sllk_un_auth*d013945 $a tymóm $2 mesh 606 2-
$3 sllk_un_auth*d014408 $a biomarkery nádorové $2 mesh 610 2-
$a ERCC1 (excision repair cross-complementation group 1) 610 2-
$a expresia ERCC1 701 -1
$3 sllk_un_auth*0026327 $a Kaira $b K. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026328 $a Endo $b M. $p Division of Diagnostic Radiology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026329 $a Shukuya $b T. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026330 $a Kenmotsu $b H. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026331 $a Naito $b T. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026332 $a Ono $b A. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026333 $a Tsuya $b A. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026334 $a Nakamura $b Y. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026335 $a Takahashi $b T. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026336 $a Murakami $b H. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026338 $a Kondo $b H. $p Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026339 $a Nakajima $b T. $p Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 701 -1
$3 sllk_un_auth*0026337 $a Jamamoto $b N. $p Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan $4 070 801 -0
$a SK $b BA006 $c 20120808 $g AACR2
Počet záznamov: 1